Literature DB >> 33866937

HBx induces hepatocellular carcinogenesis through ARRB1-mediated autophagy to drive the G1/S cycle.

Yiming Lei1,2, Xuan Xu1,2, Huiling Liu1,2, Lingjun Chen1,2, Haoxiong Zhou1,2, Jie Jiang1,2, Yidong Yang1,2, Bin Wu1,2.   

Abstract

The hepatitis B virus X protein (HBx) is involved in the process of hepatocellular carcinoma via the activation of various oncogenes. Our previous study indicated that ARBB1 (arrestin beta 1) promotes hepatocellular carcinogenesis (HCC). However, the role of ARRB1 in HBx-related HCC remains unclear. Herein, we identified that ARRB1 was upregulated by HBx in vivo and in vitro. Arrb1 deficiency suppressed HBx-induced hepatocellular carcinogenesis in several mouse models. Furthermore, knockdown of ARRB1 blocked HBx-induced macroautophagic/autophagic flux and disrupted the formation of autophagosomes. ARRB1 interacted with HBx, and the autophagic core protein MAP1LC3/LC3, a scaffolding protein, was essential for complete autophagy. Inhibition of autophagy by 3-methyladenine or interference of ATG5 or ATG7 attenuated HBx-induced cell cycle acceleration and the subsequent proliferative response via the induction of G1/S arrest. The absence of autophagy abolished the phosphorylation of CDK2 and the activity of the CDK2-CCNE1 complex. Our results demonstrate that ARRB1 plays a critical role in HBV-related HCC via modulating autophagy and the CDKN1B-CDK2-CCNE1-E2F1 axis and indicate that ARRB1 may be a potential therapeutic target for HCC.Abbreviations: ARRB1: arrestin beta 1; ACTB: actin beta; AMPK: adenosine monophosphate (AMP)-activated protein kinase; ATG5: autophagy related 5; ATG7: autophagy related 7; Baf A1: bafilomycin A1; CDK2: cyclin dependent kinase 2; CDKN1B/p27Kip1: cyclin dependent kinase inhibitor 1B; CQ: chloroquine; E2F1: E2F transcription factor 1; FBS: fetal bovine serum; GPCRs: G protein-coupled receptors; GST: glutathione S-transferase; HCC: hepatocellular carcinoma; HBV: hepatitis B virus; HBx: hepatitis B virus X protein; HMGB1: high mobility group box 1; HIF1A/HIF-1α: hypoxia inducible factor 1 subunit alpha; IHC: immunohistochemistry; JAK1: Janus kinase 1; LOX: lysyl oxidase; MAP1LC3B/LC3: microtubule associated protein 1 light chain 3 beta; MKI67: marker of proliferation Ki-67; MTOR: mechanistic target of rapamycin kinase; MAPK: mitogen-activated protein kinase; 3-MA: 3-methyladenine; NFKB/NF-κB: nuclear factor kappa B; PIK3CA: phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha; PIK3C3: phosphatidylinositol 3-kinase catalytic subunit type 3; PHHs: primary human hepatocytes; RB1: RB transcriptional corepressor 1; SQSTM1/p62: sequestosome 1; STAT: signal transducer and activator of transcription; TACR1/NK1R: tachykinin receptor 1.

Entities:  

Keywords:  ARRB1; autophagy; cell cycle; hepatitis B virus X protein; hepatocellular carcinoma

Mesh:

Substances:

Year:  2021        PMID: 33866937      PMCID: PMC8726737          DOI: 10.1080/15548627.2021.1917948

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   13.391


  50 in total

1.  Hepatitis B virus-triggered autophagy targets TNFRSF10B/death receptor 5 for degradation to limit TNFSF10/TRAIL response.

Authors:  Gu-Choul Shin; Hong Seok Kang; Ah Ram Lee; Kyun-Hwan Kim
Journal:  Autophagy       Date:  2016-10-14       Impact factor: 16.016

2.  Endothelin A receptor/β-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapy.

Authors:  Laura Rosanò; Roberta Cianfrocca; Piera Tocci; Francesca Spinella; Valeriana Di Castro; Valentina Caprara; Elisa Semprucci; Gabriella Ferrandina; Pier Giorgio Natali; Anna Bagnato
Journal:  Cancer Res       Date:  2014-11-06       Impact factor: 12.701

3.  Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts.

Authors:  K Koike; K Moriya; H Yotsuyanagi; S Iino; K Kurokawa
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

4.  Hepatitis B virus X protein sensitizes cells to starvation-induced autophagy via up-regulation of beclin 1 expression.

Authors:  Hong Tang; Liang Da; Yi Mao; Ying Li; Dong Li; Zhenhua Xu; Feng Li; Yifei Wang; Pierre Tiollais; Tsaiping Li; Mujun Zhao
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

Review 5.  Therapeutic potential of β-arrestin- and G protein-biased agonists.

Authors:  Erin J Whalen; Sudarshan Rajagopal; Robert J Lefkowitz
Journal:  Trends Mol Med       Date:  2010-12-21       Impact factor: 11.951

6.  ARRB1/β-arrestin-1 mediates neuroprotection through coordination of BECN1-dependent autophagy in cerebral ischemia.

Authors:  Pei Wang; Tian-Ying Xu; Kai Wei; Yun-Feng Guan; Xia Wang; Hui Xu; Ding-Feng Su; Gang Pei; Chao-Yu Miao
Journal:  Autophagy       Date:  2014-06-25       Impact factor: 16.016

7.  UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.

Authors:  Darshan S Chandrashekar; Bhuwan Bashel; Sai Akshaya Hodigere Balasubramanya; Chad J Creighton; Israel Ponce-Rodriguez; Balabhadrapatruni V S K Chakravarthi; Sooryanarayana Varambally
Journal:  Neoplasia       Date:  2017-07-18       Impact factor: 5.715

8.  Crosstalk between hepatitis B virus X and high-mobility group box 1 facilitates autophagy in hepatocytes.

Authors:  Sha Fu; Juan Wang; Xingwang Hu; Rong-Rong Zhou; Yongming Fu; Daolin Tang; Rui Kang; Yan Huang; Lunquan Sun; Ning Li; Xue-Gong Fan
Journal:  Mol Oncol       Date:  2018-01-24       Impact factor: 6.603

9.  Concomitant Inhibition of Cytoprotective Autophagy Augments the Efficacy of Withaferin A in Hepatocellular Carcinoma.

Authors:  Sumit Siddharth; Nethaji Muniraj; Neeraj K Saxena; Dipali Sharma
Journal:  Cancers (Basel)       Date:  2019-03-30       Impact factor: 6.639

Review 10.  The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy.

Authors:  Nina-Naomi Kreis; Frank Louwen; Juping Yuan
Journal:  Cancers (Basel)       Date:  2019-08-21       Impact factor: 6.639

View more
  5 in total

Review 1.  Role of IQ Motif-Containing GTPase-Activating Proteins in Hepatocellular Carcinoma.

Authors:  Qingqing Dai; Quratul Ain; Michael Rooney; Fei Song; Alexander Zipprich
Journal:  Front Oncol       Date:  2022-06-16       Impact factor: 5.738

2.  Unraveling the Dynamic Role of Microtubules in the HBV Life Cycle.

Authors:  Urania Georgopoulou; John Koskinas
Journal:  J Clin Transl Hepatol       Date:  2022-05-12

3.  Assessing the Prognostic Capability of Immune-Related Gene Scoring Systems in Lung Adenocarcinoma.

Authors:  Wenhao Liu; Ruihong Dong; Shuai Gao; Xiaodi Shan; Mian Li; Zhaoyan Yu; Liang Sun
Journal:  J Oncol       Date:  2022-07-31       Impact factor: 4.501

4.  Construction of Prognostic Risk Model for Small Cell Lung Cancer Based on Immune-Related Genes.

Authors:  Feng Deng; Feng Tao; Zhili Xu; Jun Zhou; Xiaowei Gong; Ruhu Zhang
Journal:  Comput Math Methods Med       Date:  2022-09-30       Impact factor: 2.809

5.  Role of ARRB1 in prognosis and immunotherapy: A Pan-Cancer analysis.

Authors:  Yingquan Ye; Haili Jiang; Yue Wu; Gaoxiang Wang; Yi Huang; Weijie Sun; Mei Zhang
Journal:  Front Mol Biosci       Date:  2022-09-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.